Hexarelin is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
Human dose-response studies confirm dose-dependent GH increases peaking at 30 minutes. Synergism demonstrated with GHRH co-administration. Cardiovascular studies showed acute increases in LVEF, cardiac output, and cardiac index. Hexarelin is not fda-approved. wada prohibited. available as research chemical.
What Does the Research Say About Hexarelin?
Human dose-response studies confirm dose-dependent GH increases peaking at 30 minutes. Synergism demonstrated with GHRH co-administration. Cardiovascular studies showed acute increases in LVEF, cardiac output, and cardiac index.
Hexarelin (Hexapeptide Growth Hormone Secretagogue) is a Growth hormone secretagogue, synthetic GHRP. Research interest has focused on its potential effects on maximum GH elevation among GHRPs, enhanced muscle growth, superior recovery, direct cardiac protection (improved LVEF and cardiac output).
What Is the Evidence for Hexarelin's Mechanism?
Activates GHS-R with high selectivity, triggering phospholipase C and inositol signaling for maximum GH secretion. Acts through three mechanisms: direct pituitary somatotroph stimulation, indirect GHRH release, and a third hypothalamic factor. Also uniquely activates cardiac CD36 and GHSR-1a receptors for direct cardioprotective effects.
These pathways have been identified through in vitro studies, animal models, and where available, human trials.
Are There Human Clinical Trials for Hexarelin?
Human dose-response studies confirm dose-dependent GH increases peaking at 30 minutes. Synergism demonstrated with GHRH co-administration. Cardiovascular studies showed acute increases in LVEF, cardiac output, and cardiac index.
The gap between preclinical promise and clinical validation remains the biggest challenge in peptide research. However, Hexarelin has shown preliminary results.
What Does the Safety Research Show?
Elevated cortisol and prolactin (dose-dependent), fluid retention, joint and muscle pain, increased appetite, fatigue, headaches, nausea. Potential cardiac hypertrophy with chronic high-dose use. More side effects than Ipamorelin due to higher potency.
Hexarelin is not fda-approved. wada prohibited. available as research chemical.
What Makes Hexarelin Unique in Research?
The most potent GH secretagogue available AND the only one with documented direct cardiac protection via CD36/GHSR-1a receptor activation — addressing both body composition and heart health.
This differentiator is important because it means Hexarelin fills a role that other compounds in its class may not fully replicate.
Bottom Line on Hexarelin Research
The evidence base for Hexarelin is growing. Key research areas include maximum GH elevation among GHRPs, enhanced muscle growth, superior recovery, direct cardiac protection (improved LVEF and cardiac output).
Stay current with PubMed searches for Hexarelin for the latest publications.
Complete Guide
Hexarelin : Benefits, Dosage, Side Effects & Research
Related Reading
- Hexarelin Dosage Guide
- Hexarelin Benefits
- Hexarelin Side Effects
- Hexarelin Stacking Guide
- Hexarelin Cycle Guide
- CJC-1295 Complete Guide
Calculate Your Hexarelin Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for Hexarelin.
Open Calculator →Research-Grade Sourcing
If you're going to research Hexarelin, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is Hexarelin?
Hexarelin (Hexapeptide Growth Hormone Secretagogue) is a Growth hormone secretagogue, synthetic GHRP. Synthetic hexapeptide designed as the most potent GH secretagogue, with stronger output than GHRP-2 or GHRP-6. It is researched for maximum GH elevation among GHRPs, enhanced muscle growth, superior recovery, direct cardiac protection (improved LVEF and cardiac output).
What is the recommended Hexarelin dosage?
Common dosages: 100-200 mcg per injection administered 1-3 times daily via subcutaneous injection. Cycle length: 8-16 weeks with breaks for receptor recovery. Half-life: GH response peaks at ~30 minutes, returns to baseline by ~240 minutes. Use our peptide calculator for exact reconstitution math.
What are the side effects of Hexarelin?
Elevated cortisol and prolactin (dose-dependent), fluid retention, joint and muscle pain, increased appetite, fatigue, headaches, nausea. Potential cardiac hypertrophy with chronic high-dose use. More side effects than Ipamorelin due to higher potency.
Is Hexarelin safe?
Hexarelin has shown a preliminary safety profile in research. Not FDA-approved. WADA prohibited. Available as research chemical. All research should follow appropriate safety protocols.